Recurrent Implantation Failure (RIF) Completed Phase 2 Trials for Human immunoglobulin G (DB00028)

Also known as: Recurrent Implantation Failure

IndicationStatusPhase
DBCOND0078432 (Recurrent Implantation Failure (RIF))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03174964Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Implantation FailureTreatment